You are at the center of everything we do at Fred Hutchinson Cancer Center. Here, we surround you with a team of specialists who work together closely to provide expertly targeted, complete care and compassionate support throughout your treatment and beyond.
We guide you every step of the way, combining our deep clinical expertise in Merkel cell carcinoma (MCC) with a commitment to meet your unique needs.
We have one of the most active MCC clinical and research programs in the world, led by Paul Nghiem, MD. Dr. Nghiem is a dermatologist and scientist at the forefront of MCC care. Our team of experts also includes surgeons, medical oncologists and radiation oncologists at our Multidisciplinary Skin Oncology Clinic.
Our skin cancer surgeon team includes experts in surgical oncology, reconstruction and head and neck surgery. This team specializes in the treatment of MCC, and you can feel confident knowing that the surgeon who cares for you is best-suited for your specific diagnosis.
Studies have shown that patients evaluated and treated at a multidisciplinary cancer center, like Fred Hutch, have better outcomes — and that the first treatment you receive for cancer is by far the most important. Patients who begin treatment at Fred Hutch often have better outcomes than those who started treatment elsewhere.
Fred Hutch is the leading cancer treatment center in the region and among the top nationally, according to U.S. News & World Report.
We are a comprehensive cancer center, a designation from the National Cancer Institute (NCI) that reflects our scientific leadership and the depth and breadth of our research to prevent, diagnose and treat cancer.
MCC is a rare and aggressive form of skin cancer. A quick diagnosis and appropriate treatment are essential to cure this disease. Fred Hutch offers comprehensive treatment from a team of experts who specialize in MCC.
Our experienced doctors are well known for providing innovative Merkel cell carcinoma treatments, including immunotherapy, vaccine protocols and gene therapy as well as surgery, radiation therapy and chemotherapy.
At Fred Hutch, you receive care from a team of providers with extensive experience in your disease. Your team includes physicians, a patient care coordinator, a registered nurse, an advanced practice provider and others, based on your needs.
We unite the leading researchers and cancer specialists of Fred Hutch and UW Medicine so you can take part in MCC clinical studies not available everywhere. Fred Hutch was a leading clinical trial site for avelumab (Bavencio), the first treatment approved by the U.S. Food and Drug Administration for metastatic MCC.
Many patients at Fred Hutchinson Cancer Center receive promising therapies by taking part in clinical trials. These research studies are done by physician-scientists from Fred Hutch and UW Medicine. They test new treatments or new ways to use current treatments.
Every advance in cancer treatment in recent years has come out of clinical trials. We offer more active clinical trials than anywhere else, which means more treatment options for patients like you.
For some people, taking part in a clinical study may be the best treatment choice. Access to clinical studies by researchers at both Fred Hutch and UW Medicine is one reason many patients come to us for care.